Owen Wolkowitz, MD

Director, Psychopharmacology Assessment Clinic at Langley Porter Psychiatric Institute

Dr. Owen Wolkowitz directs the Psychopharmacology Assessment Clinic at the Langley Porter Psychiatric Institution. The clinic offers "second opinion" consultations to doctors treating patients with depression and anxiety disorders. Wolkowitz also is a lecturer on psychopharmacology and a researcher studying how stress and hormones affect the brain. Wolkowitz is certified by the American Board of Psychiatry and Neurology.

Academic Title

Professor

More about Owen Wolkowitz

Education

University of Maryland School of Medicine 1979

Residencies

Stanford Hospital and Clinics, Psychiatry 1983

Fellowships

National Institute of Mental Health, Psychopharmacology 1986

Selected Research and Publications

  1. Wolkowitz OM. Accelerated biological aging in serious mental disorders. World Psychiatry. 2018 Jun; 17(2):144-145.
  2. Arya S, Lee S, Zahner GJ, Cohen BE, Hiramoto J, Wolkowitz OM, Khakharia A, Binney ZO, Grenon SM. The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease. J Vasc Surg. 2018 Mar 24.
  3. Mellon SH, Gautam A, Hammamieh R, Jett M, Wolkowitz OM. Metabolism, Metabolomics, and Inflammation in Posttraumatic Stress Disorder. Biol Psychiatry. 2018 May 15; 83(10):866-875.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.